Table 2. Current or past use of acetylcholinesterase inhibitors reported by patients with Alzheimer disease seen at 10 Alzheimer's Disease Research Centers of California by ethnicity^* (1999–2003) (n = 2,573).

Acetylcholinesterase inhibitor use, %	White, n = 1,879	African American, n = 144	Asian, n = 194	Latino, n = 361	p Value
Any past or current use	49	32	35	34	<0.001
Any current use	37	25	26	26	<0.001
Current donepezil use	32	19	22	22	<0.001
Current galantamine or rivastigmine use	5	6	4	4	<0.001

Two percent (n = 63) of patients with AD of other ethnicity excluded from this table.

Table 2. Current or past use of acetylcholinesterase inhibitors reported by patients with Alzheimer disease seen at 10 Alzheimer's Disease Research Centers of California by ethnicity* (1999–2003) (n = 2,573).